According to Inovio Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 307.307.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 0.9180 | -22.63% |
2023-12-31 | 1.19 | -32.22% |
2022-12-31 | 1.75 | -33.37% |
2021-12-31 | 2.63 | -19.21% |
2020-12-31 | 3.25 | -94.75% |
2019-12-31 | 61.9 | 1284.97% |
2018-12-31 | 4.47 | 70.73% |
2017-12-31 | 2.62 | -37.18% |
2016-12-31 | 4.17 | 51.02% |
2015-12-31 | 2.76 | -44.82% |
2014-12-31 | 5.00 | -56.64% |
2013-12-31 | 11.5 | 457.47% |
2012-12-31 | 2.07 | 81.71% |
2011-12-31 | 1.14 | -55.62% |
2010-12-31 | 2.56 | 33.96% |
2009-12-31 | 1.91 | 59.82% |
2008-12-31 | 1.20 | -7.77% |
2007-12-31 | 1.30 | -73.97% |
2006-12-31 | 4.99 | 75.05% |
2005-12-31 | 2.85 | -38.94% |
2004-12-31 | 4.67 | -11.77% |
2003-12-31 | 5.29 | 39.65% |
2002-12-31 | 3.79 |